BRVE insider trading

Braveheart Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
21
Last 90 days
21
Buys / sells
38% / 0%
Market cap

BRVE insider activity at a glance

FilingIQ has scored 21 insider transactions for BRVE since Aug 5, 2026. The most recent filing in our index is dated Aug 7, 2026.

Across the full history, 8 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BRVE insider trades is 67.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest BRVE Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Top insiders trading BRVE

Frequently asked

How many insider trades does FilingIQ track for BRVE?
FilingIQ tracks 21 Form 4 insider transactions for BRVE (Braveheart Bio, Inc.), covering filings from Aug 5, 2026 onwards. 21 of those were filed in the last 90 days.
Are BRVE insiders net buyers or net sellers?
Across the full Form 4 history for BRVE, 8 transactions (38%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BRVE insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every BRVE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.